BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Saturday, June 20, 2026
Home » Authors » Anette Breindl

Articles by Anette Breindl

T cells
Bench Press

Breaks are good for T-cell productivity, too

April 1, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Premetastatic niche is prepared via leaky gut in colorectal cancer; Brain metastases of breast cancer depend on fatty acid synthesis.
Read More
Brain and DNA

Tsukushi protein mutations can lead to hydrocephalus

April 1, 2021
By Anette Breindl
Researchers at Kumamoto University have identified mutations in the proteoglycan Tsukushi as a cause of hydrocephalus. The study, which was published in the March 31, 2021, issue of Science Translational Medicine, adds to the evidence that a significant proportion of hydrocephalus are due to genetic alterations.
Read More
Neurons and microglia
Bench Press

Antibodies could make things worse in neurodegeneration

March 29, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Myeloid cells differ in primary and recurrent glioblastoma.
Read More
Juvenile king penguin
Vultures and warthogs and bats, oh my!

Israeli startup goes bio(me)-prospecting in wild animals

March 26, 2021
By Anette Breindl
The animal world is full of species that can perform astonishing, and sometimes disgusting, feats. Take vultures, for example. “They eat this rotten meat that is full of pathogens and toxins, and they stay healthy,” Neta Raab told BioWorld. Raab is the co-founder and CEO of Wild Biotech Ltd., an Israeli startup that is seeking to understand gut microbiome contributions to these animal superpowers, and harness them for therapeutic use.
Read More

BioWorld MedTech’s Neurology Extra for March 26, 2021

March 26, 2021
By Andrea Applegate and Anette Breindl
Keeping you up to date on recent developments in neurology, including: New discovery improves DBS effects in Parkinson’s; Women accumulate Alzheimer’s-related protein faster; Brain cell alcohol metabolism affects behavior, addiction; Lipopolysaccharides induce neural repair sweet spot.
Read More
Silhouette made of gears
Newco news

Eliem Therapeutics Inc. has big plans for big markets

March 26, 2021
By Anette Breindl
Eliem Therapeutics Inc. is old-fashioned in the useful ways. The company is going after extremely large indications, including chronic pain and major depression. “We’re really passionate about these large markets,” Eliem President and CEO Bob Azelby told BioWorld. “These patients live in the shadows… There’s so many people suffering.”
Read More
Juvenile king penguin
Vultures and warthogs and bats, oh my!

Israeli startup goes bio(me)-prospecting in wild animals

March 25, 2021
By Anette Breindl
The animal world is full of species that can perform astonishing, and sometimes disgusting, feats. Take vultures, for example. “They eat this rotten meat that is full of pathogens and toxins, and they stay healthy,” Neta Raab told BioWorld. Raab is the co-founder and CEO of Wild Biotech Ltd., an Israeli startup that is seeking to understand gut microbiome contributions to these animal superpowers, and harness them for therapeutic use.
Read More
Heart-DNA illustration
Bench Press

Cholesterol-independent heart disease risk gene

March 25, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Ultrarare variants give insights into schizophrenia; T-cell ‘auto-aggression’ causes liver damage in NASH; Engineered myeloid cells prevent pro-metastatic microenvironments.
Read More
Influenza virus

Headless hemagglutinin makes for broad-spectrum flu vaccine

March 23, 2021
By Anette Breindl
Vaccines now in clinical trials can raise broad-spectrum antibodies against more than one form of hemagglutinin and provide protection against the flu strains that have been most troublesome from a public health perspective.
Read More
Blood cells
Bench Press

Kinase links innate immunity to MDS

March 22, 2021
By Anette Breindl
BioWorld looks at translational medicine, including: Brain cell alcohol metabolism affects behavior, addiction.
Read More
Previous 1 2 … 59 60 61 62 63 64 65 66 67 … 402 403 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing